Unique ID issued by UMIN | UMIN000027635 |
---|---|
Receipt number | R000030401 |
Scientific Title | Clinical evaluation of high resolution chorioretinal cell imaging |
Date of disclosure of the study information | 2017/06/05 |
Last modified on | 2018/12/17 13:36:51 |
Clinical evaluation of high resolution chorioretinal cell imaging
Clinical evaluation of high resolution chorioretinal cell imaging
Clinical evaluation of high resolution chorioretinal cell imaging
Clinical evaluation of high resolution chorioretinal cell imaging
Japan |
glaucoma, diabetic retinopathy, macular degeneration, choroidal degenerative disease, early stage age-related maculopathy, uvatis, retinal vein occlusion, retinal artery occlusion, strabismic amblyopia, primary macroglobulinemia, multiple myeloma, polycythemia vera, chronic myeloid leukemia, essential thrombocytosis, hypertension, dyslipidemia, systemic lupus erythematosus, etc."
Ophthalmology |
Others
NO
"To obtain images of the human ocular fundus using adaptive optics scanning laser ophthalmoscope (AOSLO) and spectral-domain optical coherence tomography (SS-OCT).
To confirm clinical utility by evaluating the index of retinal morphology or blood carculation acquired from high resolution fundus images."
Others
To search and evaluate novel index.
To study the essential factors of image quality.
Others
Others
Not applicable
1) Comparisons between healthy subjects and patients;photoreceptor density, photoreceptor arrangement regularity, capillary image, blood flow velocity, etc.
2) Comparison between AOSLO and other fundus imaging devices (OCT, etc.);
clinical findings of images and image analysis data
3) Comparison of the defference of physical charactaristics;image quality
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Diagnosis
Device,equipment |
To examine eligibility and take fundus images in a day.
20 | years-old | <= |
Not applicable |
Male and Female
Patient
1) Male or female older than 20 years-old
2) patients with:
glaucoma, diabetic retinopathy, macular degeneration, choroidal degenerative disease, early stage age-related maculopathy, uvatis, retinal vein occlusion, retinal artery occlusion, strabismic amblyopia, primary macroglobulinemia, multiple myeloma, polycythemia vera, chronic myeloid leukemia, essential thrombocytosis, hypertension, dyslipidemia, systemic lupus erythematosus, etc.
3) Subjects who sign an informed consent form to participate in the clinical study
1) Having any side-effects (hypersensitivity, rised intraocular pressure etc.) against mydriatics
2) Revealed narrow angle by slit-lamp examination
3) Subjects who a doctor in attendance declares ineligible for any reason
500
1st name | |
Middle name | |
Last name | Akitaka Tsujikawa |
Kyoto University Graduate School of Medicine
Ophthalmology & Visual Sciences
54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, JAPAN
075-751-3250
tujikawa@kuhp.kyoto-u.ac.jp
1st name | |
Middle name | |
Last name | Yuki Muraoka |
Kyoto University Graduate School of Medicine
Ophthalmology & Visual Sciences
54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, JAPAN
075-751-3250
muraoka@kuhp.kyoto-u.ac.jp
Department of Ophthalmology & Visual Sciences, Kyoto University Graduate School of Medicine
Ministry of Education, Culture, Sports, Science and Technology (MEXT)
Other
CANON INC.
NO
2017 | Year | 06 | Month | 05 | Day |
Unpublished
Open public recruiting
2017 | Year | 06 | Month | 01 | Day |
2017 | Year | 06 | Month | 09 | Day |
2017 | Year | 06 | Month | 05 | Day |
2018 | Year | 12 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030401